- Home
- CLVT vs ARWR Comparison
CLVT vs ARWR Comparison
Compare CLVT & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLVT
- ARWR
- Stock Information
- Founded
- CLVT 2016
- ARWR 2003
- Country
- CLVT United Kingdom
- ARWR United States
- Employees
- CLVT N/A
- ARWR N/A
- Industry
- CLVT EDP Services
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- CLVT Technology
- ARWR Health Care
- Exchange
- CLVT Nasdaq
- ARWR Nasdaq
- Market Cap
- CLVT 2.8B
- ARWR 2.5B
- IPO Year
- CLVT N/A
- ARWR 1993
- Fundamental
- Price
- CLVT $4.09
- ARWR $29.13
- Analyst Decision
- CLVT Hold
- ARWR Strong Buy
- Analyst Count
- CLVT 5
- ARWR 8
- Target Price
- CLVT $4.83
- ARWR $47.75
- AVG Volume (30 Days)
- CLVT 3.6M
- ARWR 2.8M
- Earning Date
- CLVT 11-05-2025
- ARWR 08-07-2025
- Dividend Yield
- CLVT N/A
- ARWR N/A
- EPS Growth
- CLVT N/A
- ARWR N/A
- EPS
- CLVT N/A
- ARWR N/A
- Revenue
- CLVT $2,500,300,000.00
- ARWR $572,976,000.00
- Revenue This Year
- CLVT N/A
- ARWR $21,619.52
- Revenue Next Year
- CLVT N/A
- ARWR N/A
- P/E Ratio
- CLVT N/A
- ARWR N/A
- Revenue Growth
- CLVT N/A
- ARWR 2816.20
- 52 Week Low
- CLVT $3.04
- ARWR $9.57
- 52 Week High
- CLVT $7.15
- ARWR $31.13
- Technical
- Relative Strength Index (RSI)
- CLVT 42.30
- ARWR 70.38
- Support Level
- CLVT $4.11
- ARWR $28.12
- Resistance Level
- CLVT $4.54
- ARWR $31.13
- Average True Range (ATR)
- CLVT 0.16
- ARWR 1.58
- MACD
- CLVT -0.03
- ARWR 0.12
- Stochastic Oscillator
- CLVT 2.17
- ARWR 78.99
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.